Literature DB >> 2103495

Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.

J Gerdes1.   

Abstract

The aim of this study is to briefly review proliferation markers that can be applied in immunohistochemistry, with special emphasis on the monoclonal antibody Ki-67. This antibody reacts with a nuclear antigen present in all proliferating cells which are in the active parts of the cell cycle, i.e. G1, S, G2, and mitosis, but which is absent in G0 cells. Thus, with the help of this antibody a determination of the growth fraction of a given human cell population is possible. The use of this method in human tumor diagnostics is illustrated by three examples: malignant melanoma, breast carcinoma, and malignant Non-Hodgkin lymphoma. The results show that evaluation of the growth fractions by Ki-67 is not only a diagnostic importance, but also has independent prognostic value. In addition, preliminary data on the immunobiochemical characterization of native and recombinant Ki-67 antigen are presented. In immunoblot analysis, Ki-67 detects a doublet with apparent molecular weights of greater than 300 kDa. Furthermore, our data show that cDNA clones isolated from Lambda gT11 cDNA libraries encode for parts of the Ki-67 antigen and must contain the sequence that encodes for the epitope recognized by the Ki-67 antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103495

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  70 in total

1.  Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.

Authors:  T G Paulson; P C Galipeau; B J Reid
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

2.  The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG).

Authors:  Ljubomir R Jakovic; Biljana S Mihaljevic; Maja D Perunicic Jovanovic; Andrija D Bogdanovic; Vesna M Cemerikic Martinovic; Tamara K Kravic; Vladimir Z Bumbasirevic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.

Authors:  P Röhlke; K Milde-Langosch; C Weyland; U Pichlmeier; W Jonat; T Löning
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.

Authors:  Yuichiro Shindo; Jacqueline Unsinger; Cary-Ann Burnham; Jonathan M Green; Richard S Hotchkiss
Journal:  Shock       Date:  2015-04       Impact factor: 3.454

5.  PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity.

Authors:  E Pierce; R Doshi; R Deane
Journal:  Mol Pathol       Date:  1998-04

6.  The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Authors:  Rocío Montes de Oca; Zachary A Gurard-Levin; Frédérique Berger; Haniya Rehman; Elise Martel; Armelle Corpet; Leanne de Koning; Isabelle Vassias; Laurence O W Wilson; Didier Meseure; Fabien Reyal; Alexia Savignoni; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  Mol Oncol       Date:  2014-11-20       Impact factor: 6.603

7.  The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.

Authors:  George Tsirakis; Constantina A Pappa; Maria Kaparou; Anna Boula; Vaitsa Katsomitrou; Athina Xekalou; Stavroula Kyriakaki; Michael G Alexandrakis
Journal:  Tumour Biol       Date:  2012-12-16

8.  Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Authors:  Dennis L Chao; Carissa A Sanchez; Patricia C Galipeau; Patricia L Blount; Thomas G Paulson; David S Cowan; Kamran Ayub; Robert D Odze; Peter S Rabinovitch; Brian J Reid
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

10.  Regeneration of corneal endothelium following complete endothelial cell loss in rat keratoplasty.

Authors:  J Schwartzkopff; L Bredow; S Mahlenbrey; D Boehringer; T Reinhard
Journal:  Mol Vis       Date:  2010-11-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.